首页> 外国专利> Anti-VEGFR2 human antibodies for anti-angiogenesis and targeted cancer therapy

Anti-VEGFR2 human antibodies for anti-angiogenesis and targeted cancer therapy

机译:抗VEGFR2人类抗体,用于抗血管生成和靶向癌症治疗

摘要

Disclosed are isolated antibodies or antigen-binding fragments thereof having a specific binding affinity for an epitope located within domain 1 or domain 3 of human vascular endothelial growth factor receptor 2 (VEGFR2; SEQ ID NO: 74). The epitope inside domain 3 of VEGFR2 is located between amino acid residues 250 and 270 of SEQ ID NO: 74. In the manufacture of a medicament for inhibiting / inhibiting tumor growth, tumor angiogenesis or inducing cancer cell cytotoxicity in a subject in need of tumor growth, inhibition of tumor angiogenesis and / or induction of cancer cell cytotoxicity, The use of the antibody or antigen-binding fragment thereof is also disclosed. Also disclosed is a method for detecting the presence of VEGFR2 in tumor vascular endothelial cells or cancer cells in a biological sample.
机译:公开了对位于人血管内皮生长因子受体2(VEGFR2; SEQ ID NO:74)的结构域1或结构域3内的表位具有特异性结合亲和力的分离的抗体或其抗原结合片段。 VEGFR2的结构域3内的表位位于SEQ ID NO:74的氨基酸残基250和270之间。在制造用于抑制/抑制需要肿瘤的受试者的肿瘤生长,肿瘤血管生成或诱导癌细胞细胞毒性的药物时生长,抑制肿瘤血管生成和/或诱导癌细胞的细胞毒性。还公开了抗体或其抗原结合片段的用途。还公开了一种用于检测生物样品中的肿瘤血管内皮细胞或癌细胞中VEGFR2的存在的方法。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号